このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Imperial Ginseng Products バランスシートの健全性

財務の健全性基準チェック /66

Imperial Ginseng Productsの総株主資本はCA$360.7K 、総負債はCA$0.0で、負債比率は0%となります。総資産と総負債はそれぞれCA$393.5KとCA$32.8Kです。

主要情報

負債資本比率

CA$0

負債

インタレスト・カバレッジ・レシオ	n/a
現金	CA$369.57k
エクイティ	CA$360.73k
負債合計	CA$32.81k
総資産	CA$393.54k

財務の健全性に関する最新情報

更新なし

Recent updates

財務状況分析

短期負債: IGPの短期資産 ( CA$393.5K ) が短期負債 ( CA$32.8K ) を超えています。

長期負債: IGPには長期負債はありません。

デット・ツー・エクイティの歴史と分析

負債レベル: IGPは負債がありません。

負債の削減: IGP負債比率が10%であった 5 年前と比べて負債がありません。

債務返済能力: IGPには負債がないため、営業キャッシュフローでカバーする必要はありません。

インタレストカバレッジ: IGPには負債がないため、利息支払いの負担は問題になりません。

Imperial Ginseng Products バランスシートの健全性

財務の健全性 基準チェック /66

主要情報

財務の健全性に関する最新情報

Recent updates

First half 2024 earnings released: CA$0.005 loss per share (vs CA$0 in 1H 2023)

Upcoming dividend of CA$2.25 per share

Imperial Ginseng Products Ltd. Announces Cash Distribution, Payable on January 26, 2024

Investor sentiment improves as stock rises 27%

New major risk - Market cap size

Insufficient new directors

First quarter 2024 earnings released: CA$0.015 loss per share (vs CA$0.11 loss in 1Q 2023)

New major risk - Market cap size

Insufficient new directors

Here's Why We Think Imperial Ginseng Products (CVE:IGP) Is Well Worth Watching

Full year 2023 earnings released: EPS: CA$0.38 (vs CA$0.31 in FY 2022)

Imperial Ginseng Products Ltd., Annual General Meeting, Dec 07, 2023

Insufficient new directors

Third quarter 2023 earnings released: CA$0.03 loss per share (vs CA$0.05 loss in 3Q 2022)

Insufficient new directors

Investor sentiment improves as stock rises 19%

Second quarter 2023 earnings released: EPS: CA$0.11 (vs CA$0.07 loss in 2Q 2022)

First quarter 2023 earnings released: CA$0.11 loss per share (vs CA$0.22 profit in 1Q 2022)

Insufficient new directors

Investor sentiment improved over the past week

Full year 2022 earnings released: EPS: CA$0.31 (vs CA$0.61 loss in FY 2021)

Imperial Ginseng Products Ltd., Annual General Meeting, Dec 07, 2022

Less than half of directors are independent

Chairman exercised options to buy CA$50k worth of stock.

Less than half of directors are independent

Third quarter 2022 earnings released: CA$0.05 loss per share (vs CA$0.03 loss in 3Q 2021)

Less than half of directors are independent

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Less than half of directors are independent

Investor sentiment improved over the past week

We Think Imperial Ginseng Products' (CVE:IGP) Robust Earnings Are Conservative

First quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings released: CA$0.61 loss per share (vs CA$1.00 loss in FY 2020)

Less than half of directors are independent

Third quarter 2021 earnings released: CA$0.03 loss per share (vs CA$0.11 loss in 3Q 2020)

Second quarter 2021 earnings released: EPS CA$0.13 (vs CA$0.07 loss in 2Q 2020)

New 90-day high: CA$0.55

How Much is Imperial Ginseng Products' (CVE:IGP) CEO Getting Paid?

New 90-day high: CA$0.37

First quarter 2021 earnings released: CA$0.57 loss per share

Full year earnings released - CA$1.00 loss per share

財務状況分析

デット・ツー・エクイティの歴史と分析

貸借対照表

健全な企業の発掘

財務の健全性基準チェック /66